Lifeward reports Q3 EPS (19c) vs (45c) last year

Reports Q3 revenue $6.195M vs $6.128M last year. “During the third quarter of 2025, Lifeward (LFWD) continued to make steady progress across commercial execution, operations, and patient access,” said Mark Grant, President and Chief Executive Officer. “Since joining the company, I’ve taken a careful look at our business and implemented a focused plan to simplify how we operate, sharpen our commercial priorities, and strengthen the processes that matter most to patients, payors and providers. The gains we saw this quarter – record Medicare placements, and meaningful improvements in operating efficiency – are early signs that this work is starting to take hold. These results reflect the commitment of our teams and the growing alignment across the organization. We recognize there is more to do to complete our transformation over the coming quarters, and the momentum we are seeing gives us confidence. With CE mark approval, broader Medicare access, and a more disciplined commercial model, Lifeward is becoming a more focused, more efficient, and more patient-centered company – positioned to serve more people and create durable long-term value.”